Welcome to COMPPARE
A Prospective Comparative Study of Outcomes with Proton and Photon Radiation in Prostate Cancer
Recent news
COMPPARE Enrolls 750 Patients
The COMPPARE team was pleased to announce in August that the study had enrolled 750 patients, 25% of its 3,000-patient goal. COMPPARE stands for…
September is Prostate Cancer Awareness Month
If you are a man between the ages of 55 and 69, September is a good time to schedule a prostate screening, one that includes both a PSA blood test…
COMPPARE Publishes Summer Newsletter
The latest Summer Edition of the COMPPARE CONNECTION is now available online.
For participants
About COMPPARE
Study goals, benefits, and other details
Locations
More than 45 partner sites across the US
Meet the Team
COMPPARE clinicians, researchers, patients, and other stakeholders
For Healthcare providers
Consortium Materials
Study-specific materials and other information.
ClinicalTrials.gov
Privately and publicly funded clinical studies conducted around the world.
VTOC Login
Medical Team sign-in page